FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tatsuya Akaki

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Anatomy

Procedures

Microbial Sensitivity Tests

Physiology

Macrophage Activation

Co-author Network

Publications

TOP 3
Itaru Dekio; Eisuke Hanada; Yuko Chinuki; Tatsuya Akaki; Mitsuhiro Kitani; Yuko Shiraishi; Sakae Kaneko; Minao Furumura; Eishin Morita
Usefulness and economic evaluation of ADSL-based live interactive teledermatology in areas with shortage of dermatologists.
Haruaki Tomioka; Chiaki Sano; Katsumasa Sato; Keiko Ogasawara; Tatsuya Akaki; Keisuke Sano; Shan Shan Cai; Toshiaki Shimizu
Combined effects of ATP on the therapeutic efficacy of antimicrobial drug regimens against Mycobacterium avium complex infection in mice and roles of cytosolic phospholipase A2-dependent mechanisms in the ATP-mediated potentiation of antimycobacterial host resistance.
Hiroaki Matsuo; K Morimoto; Tatsuya Akaki; Sakae Kaneko; K Kusatake; T Kuroda; H Niihara; M Hide; Eishin Morita
Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise-induced anaphylaxis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tatsuya Akaki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Itaru Dekio; Eisuke Hanada; Yuko Chinuki; Tatsuya Akaki; Mitsuhiro Kitani; Yuko Shiraishi; Sakae Kaneko; Minao Furumura; Eishin Morita
Usefulness and economic evaluation of ADSL-based live interactive teledermatology in areas with shortage of dermatologists.
International journal of dermatology 2010;49(11):1272-5.
2005: Haruaki Tomioka; Chiaki Sano; Katsumasa Sato; Keiko Ogasawara; Tatsuya Akaki; Keisuke Sano; Shan Shan Cai; Toshiaki Shimizu
Combined effects of ATP on the therapeutic efficacy of antimicrobial drug regimens against Mycobacterium avium complex infection in mice and roles of cytosolic phospholipase A2-dependent mechanisms in the ATP-mediated potentiation of antimycobacterial host resistance.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(10):6741-9.
2005: Hiroaki Matsuo; K Morimoto; Tatsuya Akaki; Sakae Kaneko; K Kusatake; T Kuroda; H Niihara; M Hide; Eishin Morita
Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise-induced anaphylaxis.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2005;35(4):461-6.
2002: Tatsuya Akaki; Satoshi Dekio
Contact dermatitis from arbekacin sulfate: report of a case.
The Journal of dermatology 2002;29(10):674-5.
2001: Katsumasa Sato; Tatsuya Akaki; Toshiaki Shimizu; Chiaki Sano; Keiko Ogasawara; Haruaki Tomioka
[Invasion and intracellular growth of Mycobacterium tuberculosis and Mycobacterium avium complex adapted to intramacrophagic environment within macrophages and type II alveolar epithelial cells].
Kekkaku : [Tuberculosis] 2001;76(2):53-7.
2000: Katsumasa Sato; Haruaki Tomioka; Tatsuya Akaki; S Kawahara
Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines.
International journal of antimicrobial agents 2000;16(1):25-9.
2000: Tatsuya Akaki; H Tomioka; T Shimizu; Satoshi Dekio; K Sato
Comparative roles of free fatty acids with reactive nitrogen intermediates and reactive oxygen intermediates in expression of the anti-microbial activity of macrophages against Mycobacterium tuberculosis.
Clinical and experimental immunology 2000;121(2):302-10.
2000: Tatsuya Akaki; Katsumasa Sato; Toshiaki Shimizu; Haruaki Tomioka
[Changes in antibacterial activity of murine peritoneal macrophages against Mycobacterium tuberculosis after prolonged in vitro precultivation].
Kekkaku : [Tuberculosis] 2000;75(7):477-82.
2000: Haruaki Tomioka; Katsumasa Sato; H Kajitani; Tatsuya Akaki; S Shishido
Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Antimicrobial agents and chemotherapy 2000;44(2):283-6.
1999: Haruaki Tomioka; Katsumasa Sato; Tatsuya Akaki; H Kajitani; S Kawahara; M Sakatani
Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Antimicrobial agents and chemotherapy 1999;43(12):3001-4.
1999: Toshiaki Shimizu; Chiaki Sano; Tatsuya Akaki; Keiko Ogasawara; Katsumasa Sato; Haruaki Tomioka
[Effects of the Chinese traditional medicines "mao-bushi-saishin-to" and "yokuinin" on the antimycobacterial activity of murine macrophages against Mycobacterium avium complex infection].
Kekkaku : [Tuberculosis] 1999;74(9):661-6.
1999: Katsumasa Sato; Keiko Ogasawara; Tatsuya Akaki; Haruaki Tomioka
[Internalization and replication of Mycobacterium tuberculosis and M. avium complex within type II alveolar epithelial cell line].
Kekkaku : [Tuberculosis] 1999;74(9):655-60.
1999: Toshiaki Shimizu; Haruaki Tomioka; Katsumasa Sato; Tatsuya Akaki; Keiko Ogasawara; S Kawahara
[Therapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with glycyrrhizin against Mycobacterium avium complex infection in mice].
Kekkaku : [Tuberculosis] 1999;74(8):617-21.
1999: Katsumasa Sato; Keiko Ogasawara; Tatsuya Akaki; Haruaki Tomioka
[MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines].
Kekkaku : [Tuberculosis] 1999;74(7):571-7.
1999: Toshiaki Shimizu; Haruaki Tomioka; Katsumasa Sato; Chiaki Sano; Tatsuya Akaki; Satoshi Dekio; Y Yamada; T Kamei; H Shibata; N Higashi
Effects of the Chinese traditional medicine mao-bushi-saishin-to on therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, against Mycobacterium avium infection in mice.
Antimicrobial agents and chemotherapy 1999;43(3):514-9.
1998: Katsumasa Sato; Tatsuya Akaki; Haruaki Tomioka
Differential potentiation of anti-mycobacterial activity and reactive nitrogen intermediate-producing ability of murine peritoneal macrophages activated by interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha).
Clinical and experimental immunology 1998;112(1):63-8.
1998: Haruaki Tomioka; Katsumasa Sato; Toshiaki Shimizu; Tatsuya Akaki
[Nontuberculous mycobacteriosis; the present status and in the future. Mechanisms of host resistance to Mycobacterium avium complex and Mycobacterium tuberculosis infection].
Kekkaku : [Tuberculosis] 1998;73(2):71-6.
1998: Katsumasa Sato; Toshiaki Shimizu; Tatsuya Akaki; Haruaki Tomioka
[Usefulness of MycoDot test for the detection of anti-mycobacterial antibodies as an aid in the diagnosis of experimental Mycobacterium tuberculosis and Mycobacterium avium complex infections in mice].
Kekkaku : [Tuberculosis] 1998;73(2):47-52.
1998: Katsumasa Sato; Tatsuya Akaki; Haruaki Tomioka
Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages.
The Journal of antimicrobial chemotherapy 1998;41(1):77-83.
1997: Tatsuya Akaki; Katsumasa Sato; Toshiaki Shimizu; Chiaki Sano; H Kajitani; Satoshi Dekio; Haruaki Tomioka
Effector molecules in expression of the antimicrobial activity of macrophages against Mycobacterium avium complex: roles of reactive nitrogen intermediates, reactive oxygen intermediates, and free fatty acids.
Journal of leukocyte biology 1997;62(6):795-804.
1997: Tatsuya Akaki; Katsumasa Sato; Toshiaki Shimizu; Haruaki Tomioka; S Kawahara
[In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice].
Kekkaku : [Tuberculosis] 1997;72(8):491-7.
1997: Haruaki Tomioka; Katsumasa Sato; Chiaki Sano; Tatsuya Akaki; Toshiaki Shimizu; H Kajitani; H Saito
Effector molecules of the host defence mechanism against Mycobacterium avium complex: the evidence showing that reactive oxygen intermediates, reactive nitrogen intermediates, and free fatty acids each alone are not decisive in expression of macrophage antimicrobial activity against the parasites.
Clinical and experimental immunology 1997;109(2):248-54.
1997: Katsumasa Sato; Tatsuya Akaki; Haruaki Tomioka
[Anti-Mycobacterium avium complex activities of KRM-1648, clarithromycin and levofloxacin in 7HSF medium at peak or average blood concentrations after their oral administration of clinical dosages].
Kekkaku : [Tuberculosis] 1997;72(7):449-53.
1997: Haruaki Tomioka; Katsumasa Sato; Toshiaki Shimizu; Chiaki Sano; Tatsuya Akaki; H Saito; K Fujii; T Hidaka
Effects of benzoxazinorifamycin KRM-1648 on cytokine production at sites of Mycobacterium avium complex infection induced in mice.
Antimicrobial agents and chemotherapy 1997;41(2):357-62.